Back to Search
RONALD DRENGLER, M.D.
M.D.
Medical Oncology Physician
NPI: 1265459168IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
J4091(TX)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1988
Research & Publications (10)
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
PMID 18795290·Cancer Chemother Pharmacol·2009
3-trial
Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
PMID 16317586·Breast Cancer Res Treat·2006
8-other
Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II trial.
PMID 15160349·Cancer·2004
3-trial
A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms.
PMID 15014015·Clin Cancer Res·2004
3-trial
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies.
PMID 11118470·J Clin Oncol·2000
8-other
Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies.
PMID 11106122·Ann Oncol·2000
3-trial
Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer.
PMID 11099327·J Clin Oncol·2000
3-trial
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
PMID 10999729·Clin Cancer Res·2000
8-other
DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies.
PMID 10963644·J Clin Oncol·2000
3-trial
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies.
PMID 10623707·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4383 MEDICAL DR
SAN ANTONIO, TX 78229 - Phone
- (210) 593-5700
Quick Facts
- NPI
- 1265459168
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 10
Are you this provider?
Claim Your Profile